Stress is associated with increased Crohn's Disease (CD) activity. This pilot study tested whether pediatric patients with CD reporting higher levels of perceived stress exhibited differences in the fecal microbiome and metabolome. The perceived stress scale (PSS) questionnaire was administered within 2 days of collecting a stool sample for microbiome (using 16S rRNA gene sequencing) and metabolome (using NMR metabolomics) analyses. Higher levels of perceived stress were correlated with increased disease activity on the short Pediatric Crohn's Disease Activity Index (sPCDAI). Patients with High PSS scores vs. Low PSS scores based on a median split had significantly lower relative abundances of Firmicutes and Anaerostipes, as well as higher relative abundances of Parabacteroides. Fecal alanine and nicotinate were also significantly different in patients with High vs. Low PSS Scores. This pilot study suggests that the fecal microbiome and metabolome differs in pediatric patients with CD and high perceived stress.
Keywords: Metabolome; Microbiome; Pediatric Crohn’s disease; Stress.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of Interests
The authors do not have any conflicts of interests that affect the conduct or interpretation of this study.
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral NutritionV Svolos et al. Gastroenterology 156 (5), 1354-1367.e6. PMID 30550821. - Randomized Controlled TrialCD-TREAT replicates EEN changes in the microbiome, decreases gut inflammation, is well tolerated, and is potentially effective in patients with active CD. ClinicalTrials. …
Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated With Depression by 16S rRNA Gene Sequencing and LC/MS-based MetabolomicsM Yu et al. J Pharm Biomed Anal 138, 231-239. PMID 28219800.As a prevalent, life-threatening and highly recurrent psychiatric illness, depression is characterized by a wide range of pathological changes; however, its etiology rema …
Timing for the Second Fecal Microbiota Transplantation to Maintain the Long-Term Benefit From the First Treatment for Crohn's DiseaseP Li et al. Appl Microbiol Biotechnol 103 (1), 349-360. PMID 30357440. - Clinical TrialIncreasing evidence has shown that fecal microbiota transplantation (FMT) could be a promising treatment option for Crohn's disease (CD). However, the frequency of FMT fo …
Recent Advances in Characterizing the Gastrointestinal Microbiome in Crohn's Disease: A Systematic ReviewEK Wright et al. Inflamm Bowel Dis 21 (6), 1219-28. PMID 25844959. - ReviewChanges in microbial composition and function have been described, although a causative role remains to be established. Larger, prospective, and longitudinal studies are …
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement TherapiesS Khanna et al. Gastroenterol Clin North Am 46 (3), 481-492. PMID 28838410. - ReviewIndividuals with a genetic predisposition to Crohn's disease develop aberrant immune responses to environmental triggers. The gastrointestinal microbiota is increasingly …